FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2166152583> ?p ?o ?g. }

• W2166152583 endingPage "405" @default.
• W2166152583 startingPage "396" @default.
• W2166152583 abstract "<h3>Background</h3> Antithrombotic therapy reduces stroke, embolism and mortality in patients with atrial fibrillation (AF); however, meta-analyses have focused on pairwise comparisons of treatments. <h3>Objective</h3> To synthesise the evidence from trials using a multiple treatment comparison methods thereby permitting a broader comparison across multiple therapies. <h3>Design, setting, patients</h3> Randomised controlled trials in patients with AF of antithrombotics were identified from MEDLINE, Embase, and Cochrane Central Register of Controlled Trials through May 2012. We performed a random-effects model within a Bayesian framework using Markov Chain Monte Carlo simulation to calculate pooled OR and 95% credibility intervals (CrI). We also ranked therapies by their likelihood of leading to the best results for the outcomes. <h3>Main outcome measure</h3> Multiple endpoints including stroke, embolism, death and bleeding. <h3>Results</h3> We identified 20 studies with 79 808 patients allocated to 8 treatments: ASA, ASA plus clopidogrel, vitamin K antagonists (VKAs), dabigatran 110 mg, dabigatran 150 mg, rivaroxaban, apixaban or placebo/control. Compared with placebo/control, dabigatran 150 mg was associated with the lowest risk of stroke (OR=0.25, 0.15–0.43), the composite of ischaemic stroke or systemic embolism (OR=0.26, 0.12–0.54) and mortality (OR=0.53, 0.28–0.88). ASA plus clopidogrel was associated with the highest risk of major bleeding (OR=3.65, 1.22–13.56). In simulated comparisons, the novel oral anticoagulants ranked better than VKA or antiplatelet therapies for prevention of stroke, ischaemic stroke or systemic embolism and mortality. <h3>Conclusions</h3> In this network meta-analysis, novel oral anticoagulants were the most promising treatments to reduce stroke, stroke or systemic embolism, and all-cause mortality in patients with AF." @default.
• W2166152583 created "2016-06-24" @default.
• W2166152583 creator A5045665978 @default.
• W2166152583 creator A5063561727 @default.
• W2166152583 creator A5083405174 @default.
• W2166152583 date "2013-09-05" @default.
• W2166152583 modified "2023-10-16" @default.
• W2166152583 title "Current and new oral antithrombotics in non-valvular atrial fibrillation: a network meta-analysis of 79 808 patients" @default.
• W2166152583 cites W1967046500 @default.
• W2166152583 cites W1987034302 @default.
• W2166152583 cites W1999468381 @default.
• W2166152583 cites W2014924181 @default.
• W2166152583 cites W2029345778 @default.
• W2166152583 cites W2031875672 @default.
• W2166152583 cites W2035626182 @default.
• W2166152583 cites W2040452288 @default.
• W2166152583 cites W2047926237 @default.
• W2166152583 cites W2057250169 @default.
• W2166152583 cites W2074119210 @default.
• W2166152583 cites W2076047772 @default.
• W2166152583 cites W2080111455 @default.
• W2166152583 cites W2093626671 @default.
• W2166152583 cites W2097854437 @default.
• W2166152583 cites W2100365169 @default.
• W2166152583 cites W2101909990 @default.
• W2166152583 cites W2103053426 @default.
• W2166152583 cites W2103245453 @default.
• W2166152583 cites W2105669432 @default.
• W2166152583 cites W2113089341 @default.
• W2166152583 cites W2118243040 @default.
• W2166152583 cites W2125435699 @default.
• W2166152583 cites W2127211051 @default.
• W2166152583 cites W2130909191 @default.
• W2166152583 cites W2136489990 @default.
• W2166152583 cites W2138710687 @default.
• W2166152583 cites W2139662446 @default.
• W2166152583 cites W2143034000 @default.
• W2166152583 cites W2144625636 @default.
• W2166152583 cites W2149388786 @default.
• W2166152583 cites W2150085535 @default.
• W2166152583 cites W2159193915 @default.
• W2166152583 cites W2159730165 @default.
• W2166152583 cites W2161817962 @default.
• W2166152583 cites W2162508946 @default.
• W2166152583 cites W2435343268 @default.
• W2166152583 cites W2465663631 @default.
• W2166152583 cites W2481569543 @default.
• W2166152583 cites W4205725164 @default.
• W2166152583 cites W4362054082 @default.
• W2166152583 doi "https://doi.org/10.1136/heartjnl-2013-304347" @default.
• W2166152583 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/24009224" @default.
• W2166152583 hasPublicationYear "2013" @default.
• W2166152583 type Work @default.
• W2166152583 sameAs 2166152583 @default.
• W2166152583 citedByCount "56" @default.
• W2166152583 countsByYear W21661525832014 @default.
• W2166152583 countsByYear W21661525832015 @default.
• W2166152583 countsByYear W21661525832016 @default.
• W2166152583 countsByYear W21661525832017 @default.
• W2166152583 countsByYear W21661525832018 @default.
• W2166152583 countsByYear W21661525832019 @default.
• W2166152583 countsByYear W21661525832020 @default.
• W2166152583 countsByYear W21661525832021 @default.
• W2166152583 countsByYear W21661525832022 @default.
• W2166152583 countsByYear W21661525832023 @default.
• W2166152583 crossrefType "journal-article" @default.
• W2166152583 hasAuthorship W2166152583A5045665978 @default.
• W2166152583 hasAuthorship W2166152583A5063561727 @default.
• W2166152583 hasAuthorship W2166152583A5083405174 @default.
• W2166152583 hasConcept C126322002 @default.
• W2166152583 hasConcept C127413603 @default.
• W2166152583 hasConcept C164705383 @default.
• W2166152583 hasConcept C168563851 @default.
• W2166152583 hasConcept C2776301958 @default.
• W2166152583 hasConcept C2777628954 @default.
• W2166152583 hasConcept C2777849778 @default.
• W2166152583 hasConcept C2778661090 @default.
• W2166152583 hasConcept C2778810321 @default.
• W2166152583 hasConcept C2779161974 @default.
• W2166152583 hasConcept C2780638905 @default.
• W2166152583 hasConcept C2780645631 @default.
• W2166152583 hasConcept C71924100 @default.
• W2166152583 hasConcept C78519656 @default.
• W2166152583 hasConcept C95190672 @default.
• W2166152583 hasConceptScore W2166152583C126322002 @default.
• W2166152583 hasConceptScore W2166152583C127413603 @default.
• W2166152583 hasConceptScore W2166152583C164705383 @default.
• W2166152583 hasConceptScore W2166152583C168563851 @default.
• W2166152583 hasConceptScore W2166152583C2776301958 @default.
• W2166152583 hasConceptScore W2166152583C2777628954 @default.
• W2166152583 hasConceptScore W2166152583C2777849778 @default.
• W2166152583 hasConceptScore W2166152583C2778661090 @default.
• W2166152583 hasConceptScore W2166152583C2778810321 @default.
• W2166152583 hasConceptScore W2166152583C2779161974 @default.
• W2166152583 hasConceptScore W2166152583C2780638905 @default.
• W2166152583 hasConceptScore W2166152583C2780645631 @default.
• W2166152583 hasConceptScore W2166152583C71924100 @default.
• W2166152583 hasConceptScore W2166152583C78519656 @default.

• next